Page last updated: 2024-08-23

rimcazole and Breast Neoplasms

rimcazole has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aderemi, J; Chakraborty, K; Cortez, B; Dejoie, J; Happy, M; Sauane, M; Zajac, CK	1
Appleyard, MV; Box, G; Campbell, LA; Cooper, MA; Downes, CP; Eccles, S; Ferguson, MJ; Hayes, A; Howie, J; Lambert, JJ; Leslie, NR; McLean, D; McTavish, N; Murray, K; Nutley, B; O'Neill, M; Peters, JA; Prescott, AR; Raynaud, F; Safrany, ST; Samson, J; Spruce, BA; Thompson, AM; Watt, S	1

Other Studies

2 other study(ies) available for rimcazole and Breast Neoplasms

Article	Year
Sigma 1 Receptor antagonist potentiates the anti-cancer effect of p53 by regulating ER stress, ROS production, Bax levels, and caspase-3 activation. Biochemical and biophysical research communications, 2015, Jan-09, Volume: 456, Issue:2 Topics: Adenoviridae; Antineoplastic Agents; bcl-2-Associated X Protein; Breast Neoplasms; Carbazoles; Caspase 3; Cell Line, Tumor; Endoplasmic Reticulum Stress; Female; Gene Knockdown Techniques; Genetic Therapy; Humans; Reactive Oxygen Species; Receptors, sigma; RNA, Small Nuclear; Sigma-1 Receptor; Tumor Suppressor Protein p53	2015
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer research, 2004, Jul-15, Volume: 64, Issue:14 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium Signaling; Carbazoles; Caspases; Cattle; Cell Division; Cell Line, Tumor; Enzyme Activation; Ethylenediamines; Haloperidol; Humans; Isoenzymes; Lung Neoplasms; Male; Mice; Mice, Nude; Phospholipase C delta; Piperazines; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, sigma; Sigma-1 Receptor; Type C Phospholipases; Xenograft Model Antitumor Assays	2004

Article

Year

Sigma 1 Receptor antagonist potentiates the anti-cancer effect of p53 by regulating ER stress, ROS production, Bax levels, and caspase-3 activation.

Biochemical and biophysical research communications, 2015, Jan-09, Volume: 456, Issue:2

Topics: Adenoviridae; Antineoplastic Agents; bcl-2-Associated X Protein; Breast Neoplasms; Carbazoles; Caspase 3; Cell Line, Tumor; Endoplasmic Reticulum Stress; Female; Gene Knockdown Techniques; Genetic Therapy; Humans; Reactive Oxygen Species; Receptors, sigma; RNA, Small Nuclear; Sigma-1 Receptor; Tumor Suppressor Protein p53

2015

Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.

Cancer research, 2004, Jul-15, Volume: 64, Issue:14

Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium Signaling; Carbazoles; Caspases; Cattle; Cell Division; Cell Line, Tumor; Enzyme Activation; Ethylenediamines; Haloperidol; Humans; Isoenzymes; Lung Neoplasms; Male; Mice; Mice, Nude; Phospholipase C delta; Piperazines; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, sigma; Sigma-1 Receptor; Type C Phospholipases; Xenograft Model Antitumor Assays

2004